Exact Therapeutics AS
🇳🇴Norway
- Country
- 🇳🇴Norway
- Ownership
- Public
- Established
- 2012-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://exact-tx.com
Acoustic Cluster Therapy (ACT) with Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
Phase 2
Not yet recruiting
- Conditions
- Locally Advanced Pancreatic Adenocarcinoma
- Interventions
- Combination Product: Acoustic Cluster TherapyDrug: Modified FOLFIRINOX
- First Posted Date
- 2025-02-27
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- EXACT Therapeutics AS
- Target Recruit Count
- 25
- Registration Number
- NCT06850623
PS101-mediated ACT With Chemotherapy in Liver Metastases From Cancer of Gastrointestinal Origin
Phase 1
Terminated
- Conditions
- Solid TumorColorectal Cancer
- Interventions
- Drug: 20 uL/kg PS101Drug: 40 uL/kg PS101Device: Ultrasound
- First Posted Date
- 2019-07-16
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- EXACT Therapeutics AS
- Target Recruit Count
- 11
- Registration Number
- NCT04021277
- Locations
- 🇳🇴
Oslo University Hospital HF, Oslo, Norway
🇬🇧Cambridge University Hospitals NHS Foundation Trust, Addenbrookes Hospital, Cambridge, United Kingdom
🇬🇧Freeman Hospital, Newcastle Upon Tyne, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath